ROSELABS FINANCE LTD.

Roselabs Finance Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the quarter ended June 30, 2026. The company has informed its designated persons about this closure as per its Code of Conduct for Regulating, Monitoring & Reporting of Trading.

Roselabs Finance Ltd has re-appointed Mr. Raghava Reddy Balineni as Managing Director for a further period of five years commencing from May 31, 2026. The re-appointment is based on the recommendations of the Nomination and Remuneration Committee and is subject to the approval of the Members of the Company. Mr. Balineni has been associated with the Lodha Group since 2020 and has over 31 years of experience in taxation and general management.

Roselabs Finance Ltd. announced the appointment of M/s Walker Chandiok & Co., LLP as its new Statutory Auditor for a five-year term, effective from FY 2026-27, subject to shareholder approval at the 32nd Annual General Meeting. This follows the retirement of the previous auditors, M/s. MSKA & Associates LLP, after completing their second consecutive five-year term. Additionally, the Board approved the appointment of M/s Shravan A. Gupta & Associates as the Secretarial Auditor for the financial year 2026-27.

Roselabs Finance Ltd's Board of Directors, at a meeting on April 16, 2026, approved the appointment of M/s. Walker Chandiok & Co., LLP as the new Statutory Auditors for a five-year term, effective from FY 2026-27. This appointment replaces M/s. MSKA & Associates LLP, who are completing their second consecutive term, and is subject to shareholder approval at the upcoming 32nd Annual General Meeting. Additionally, M/s Shravan A. Gupta & Associates were appointed as the Secretarial Auditors for the financial year 2026-27.

Roselabs Finance Ltd's Board of Directors approved the Audited Financial Results for the quarter and financial year ended March 31, 2026, at their meeting held on Thursday, April 16, 2026. The company's Statutory Auditors, M/s. MSKA & Associates LLP, issued an audit report with an unmodified opinion on these financial results. The approved results along with the Auditors' Report have been enclosed with the filing. The board meeting commenced at 5:30 p.m. IST and concluded at 5:55 p.m. IST.

Roselabs Finance Limited's Board of Directors, at its meeting on Thursday, April 16, 2026, approved the Audited Financial Results for the quarter and financial year ended March 31, 2026. The company's Statutory Auditors, M/s. MSKA & Associates LLP, issued an audit report with an unmodified opinion on these financial results. The filing confirms compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Roselabs Finance Ltd has announced that its Board of Directors will convene a meeting on Thursday, April 16, 2026. The primary agenda for this meeting is to consider and approve the Audited Financial Results for the quarter and the full financial year ended March 31, 2026. In compliance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for designated persons has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of these financial results.

Roselabs Finance Ltd has announced the closure of its trading window as per the company's Code of Conduct. The closure will be effective from April 1, 2026, and will continue till the expiry of 48 hours after the declaration of the audited financial results for the quarter and financial year ending March 31, 2026. The decision has been communicated to the designated persons of the company as per the Code.

Roselabs Finance Ltd has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at ₹ 120.75 crores for the quarter and ₹ 362 crores for the nine months period. The profit before tax for the quarter is ₹ (3.67) crores and ₹ (10.84) crores for the nine months period. The company's total comprehensive income (loss) stands at ₹ (3.67) crores for the quarter and ₹ (29.17) crores for the nine months period. The earnings per share (EPS) for the quarter is ₹ (0.04) and ₹ (0.25) for the year ended 31st March 2025.

Roselabs Finance Ltd has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported a net loss of ₹ 29.17 Crores for the year ended December 31, 2025. The loss for the quarter ended December 31, 2025, was ₹ 3.47 Crores. The company's revenue from operations for the quarter was ₹ 120.75 Crores, a decrease from the ₹ 122.59 Crores in the same quarter of the previous year. The total comprehensive income for the quarter was ₹ (3.67) Crores. The company operates in the real estate development sector and is in the process of merging with Lodha Developers Limited.